Annual Current Liabilities
$31.06 M
+$3.15 M+11.27%
31 December 2023
Summary:
Anika Therapeutics annual total current liabilities is currently $31.06 million, with the most recent change of +$3.15 million (+11.27%) on 31 December 2023. During the last 3 years, it has fallen by -$5.81 million (-15.75%). ANIK annual current liabilities is now -15.75% below its all-time high of $36.87 million, reached on 31 December 2020.ANIK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$25.49 M
-$628.00 K-2.40%
30 September 2024
Summary:
Anika Therapeutics quarterly total current liabilities is currently $25.49 million, with the most recent change of -$628.00 thousand (-2.40%) on 30 September 2024. Over the past year, it has dropped by -$2.57 million (-9.16%). ANIK quarterly current liabilities is now -45.73% below its all-time high of $46.97 million, reached on 31 March 2021.ANIK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.3% | -9.2% |
| 3 y3 years | -15.8% | -11.4% |
| 5 y5 years | +175.1% | +127.7% |
ANIK Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.8% | +11.3% | -17.9% | +8.7% |
| 5 y | 5 years | -15.8% | +175.1% | -45.7% | +127.7% |
| alltime | all time | -15.8% | +3782.4% | -45.7% | +6273.3% |
Anika Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.49 M(-2.4%) |
| June 2024 | - | $26.12 M(-8.2%) |
| Mar 2024 | - | $28.46 M(-8.4%) |
| Dec 2023 | $31.06 M(+11.3%) | $31.06 M(+10.7%) |
| Sept 2023 | - | $28.06 M(+19.6%) |
| June 2023 | - | $23.46 M(-18.3%) |
| Mar 2023 | - | $28.69 M(+2.8%) |
| Dec 2022 | $27.91 M(-6.3%) | $27.91 M(+5.9%) |
| Sept 2022 | - | $26.35 M(-10.5%) |
| June 2022 | - | $29.43 M(+9.0%) |
| Mar 2022 | - | $26.99 M(-9.4%) |
| Dec 2021 | $29.80 M(-19.2%) | $29.80 M(+3.6%) |
| Sept 2021 | - | $28.77 M(-30.4%) |
| June 2021 | - | $41.37 M(-11.9%) |
| Mar 2021 | - | $46.97 M(+27.4%) |
| Dec 2020 | $36.87 M(+126.5%) | $36.87 M(+18.4%) |
| Sept 2020 | - | $31.14 M(+11.6%) |
| June 2020 | - | $27.91 M(+6.6%) |
| Mar 2020 | - | $26.19 M(+60.9%) |
| Dec 2019 | $16.28 M(+44.2%) | $16.28 M(+45.4%) |
| Sept 2019 | - | $11.20 M(+7.8%) |
| June 2019 | - | $10.39 M(-10.5%) |
| Mar 2019 | - | $11.60 M(+2.8%) |
| Dec 2018 | $11.29 M(-13.6%) | $11.29 M(+21.3%) |
| Sept 2018 | - | $9.30 M(-25.8%) |
| June 2018 | - | $12.53 M(-11.3%) |
| Mar 2018 | - | $14.12 M(+8.0%) |
| Dec 2017 | $13.07 M(+48.6%) | $13.07 M(+11.7%) |
| Sept 2017 | - | $11.71 M(-12.9%) |
| June 2017 | - | $13.44 M(+31.6%) |
| Mar 2017 | - | $10.22 M(+16.1%) |
| Dec 2016 | $8.80 M(-49.1%) | $8.80 M(+15.9%) |
| Sept 2016 | - | $7.59 M(-27.9%) |
| June 2016 | - | $10.52 M(-3.1%) |
| Mar 2016 | - | $10.87 M(-37.1%) |
| Dec 2015 | $17.28 M(+189.3%) | $17.28 M(+30.5%) |
| Sept 2015 | - | $13.24 M(+66.4%) |
| June 2015 | - | $7.96 M(+29.2%) |
| Mar 2015 | - | $6.16 M(+3.1%) |
| Dec 2014 | $5.97 M(-35.7%) | $5.97 M(-7.2%) |
| Sept 2014 | - | $6.43 M(-12.1%) |
| June 2014 | - | $7.32 M(-5.1%) |
| Mar 2014 | - | $7.71 M(-16.9%) |
| Dec 2013 | $9.28 M(-35.8%) | $9.28 M(-10.4%) |
| Sept 2013 | - | $10.36 M(-11.5%) |
| June 2013 | - | $11.70 M(+8.9%) |
| Mar 2013 | - | $10.74 M(-25.7%) |
| Dec 2012 | $14.45 M(-0.6%) | $14.45 M(+18.9%) |
| Sept 2012 | - | $12.15 M(-20.1%) |
| June 2012 | - | $15.21 M(+18.1%) |
| Mar 2012 | - | $12.88 M(-11.4%) |
| Dec 2011 | $14.54 M(-24.9%) | $14.54 M(-4.0%) |
| Sept 2011 | - | $15.14 M(-12.9%) |
| June 2011 | - | $17.38 M(-3.6%) |
| Mar 2011 | - | $18.04 M(-6.9%) |
| Dec 2010 | $19.37 M(+17.2%) | $19.37 M(+5.7%) |
| Sept 2010 | - | $18.33 M(+11.1%) |
| June 2010 | - | $16.50 M(+3.3%) |
| Mar 2010 | - | $15.98 M(-3.3%) |
| Dec 2009 | $16.52 M(+82.9%) | $16.52 M(+79.0%) |
| Sept 2009 | - | $9.23 M(-2.7%) |
| June 2009 | - | $9.49 M(+5.1%) |
| Mar 2009 | - | $9.02 M(-0.1%) |
| Dec 2008 | $9.03 M | $9.03 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | $9.41 M(-6.8%) |
| June 2008 | - | $10.09 M(+14.2%) |
| Mar 2008 | - | $8.84 M(-16.9%) |
| Dec 2007 | $10.64 M(+94.8%) | $10.64 M(+4.5%) |
| Sept 2007 | - | $10.18 M(+35.5%) |
| June 2007 | - | $7.51 M(+43.0%) |
| Mar 2007 | - | $5.25 M(-3.8%) |
| Dec 2006 | $5.46 M(-6.3%) | $5.46 M(-19.2%) |
| Sept 2006 | - | $6.76 M(+10.9%) |
| June 2006 | - | $6.09 M(+28.0%) |
| Mar 2006 | - | $4.76 M(-18.3%) |
| Dec 2005 | $5.83 M(-16.1%) | $5.83 M(-5.7%) |
| Sept 2005 | - | $6.18 M(+24.9%) |
| June 2005 | - | $4.95 M(-19.7%) |
| Mar 2005 | - | $6.16 M(-11.3%) |
| Dec 2004 | $6.95 M(+232.6%) | $6.95 M(+15.9%) |
| Sept 2004 | - | $5.99 M(+16.6%) |
| June 2004 | - | $5.14 M(-33.0%) |
| Mar 2004 | - | $7.67 M(+267.0%) |
| Dec 2003 | $2.09 M(-30.9%) | $2.09 M(-19.7%) |
| Sept 2003 | - | $2.60 M(+21.9%) |
| June 2003 | - | $2.13 M(-17.8%) |
| Mar 2003 | - | $2.60 M(-14.1%) |
| Dec 2002 | $3.02 M(+7.5%) | $3.02 M(-14.2%) |
| Sept 2002 | - | $3.52 M(+14.6%) |
| June 2002 | - | $3.07 M(+9.6%) |
| Mar 2002 | - | $2.80 M(-0.3%) |
| Dec 2001 | $2.81 M(+24.1%) | $2.81 M(-14.0%) |
| Sept 2001 | - | $3.27 M(-13.3%) |
| June 2001 | - | $3.77 M(+59.4%) |
| Mar 2001 | - | $2.36 M(+4.3%) |
| Dec 2000 | $2.27 M(-43.3%) | $2.27 M(-64.1%) |
| Sept 2000 | - | $6.32 M(+35.5%) |
| June 2000 | - | $4.66 M(+1.1%) |
| Mar 2000 | - | $4.61 M(+15.2%) |
| Dec 1999 | $4.00 M(+66.7%) | $4.00 M(+81.8%) |
| Sept 1999 | - | $2.20 M(-8.3%) |
| June 1999 | - | $2.40 M(-11.1%) |
| Mar 1999 | - | $2.70 M(+12.5%) |
| Dec 1998 | $2.40 M(0.0%) | $2.40 M(+20.0%) |
| Sept 1998 | - | $2.00 M(-4.8%) |
| June 1998 | - | $2.10 M(0.0%) |
| Mar 1998 | - | $2.10 M(-12.5%) |
| Dec 1997 | $2.40 M(+33.3%) | $2.40 M(+14.3%) |
| Sept 1997 | - | $2.10 M(+16.7%) |
| June 1997 | - | $1.80 M(+20.0%) |
| Mar 1997 | - | $1.50 M(0.0%) |
| Dec 1996 | $1.80 M(+28.6%) | - |
| Nov 1996 | - | $1.50 M(+7.1%) |
| Aug 1996 | - | $1.40 M(-12.5%) |
| Aug 1996 | $1.40 M(-17.6%) | - |
| May 1996 | - | $1.60 M(-15.8%) |
| Feb 1996 | - | $1.90 M(+5.6%) |
| Nov 1995 | - | $1.80 M(+5.9%) |
| Aug 1995 | $1.70 M(+112.5%) | $1.70 M(-10.5%) |
| May 1995 | - | $1.90 M(+280.0%) |
| Feb 1995 | - | $500.00 K(-16.7%) |
| Nov 1994 | - | $600.00 K(-25.0%) |
| Aug 1994 | $800.00 K(-38.5%) | $800.00 K(0.0%) |
| May 1994 | - | $800.00 K(+33.3%) |
| Feb 1994 | - | $600.00 K(-45.5%) |
| Nov 1993 | - | $1.10 M(-15.4%) |
| Aug 1993 | $1.30 M | $1.30 M(+225.0%) |
| May 1993 | - | $400.00 K |
FAQ
- What is Anika Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Anika Therapeutics?
- What is Anika Therapeutics annual current liabilities year-on-year change?
- What is Anika Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Anika Therapeutics?
- What is Anika Therapeutics quarterly current liabilities year-on-year change?
What is Anika Therapeutics annual total current liabilities?
The current annual current liabilities of ANIK is $31.06 M
What is the all time high annual current liabilities for Anika Therapeutics?
Anika Therapeutics all-time high annual total current liabilities is $36.87 M
What is Anika Therapeutics annual current liabilities year-on-year change?
Over the past year, ANIK annual total current liabilities has changed by +$3.15 M (+11.27%)
What is Anika Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ANIK is $25.49 M
What is the all time high quarterly current liabilities for Anika Therapeutics?
Anika Therapeutics all-time high quarterly total current liabilities is $46.97 M
What is Anika Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ANIK quarterly total current liabilities has changed by -$2.57 M (-9.16%)